As commercialization strategies evolve amid Covid-19, and supply chains continue to trend toward diversification, the only way for businesses to control their destiny is to double down on quality standards.

The U.S. Department of Defense and more than 80 companies, universities, states, and research institutes will invest at least $275 million during the next seven years to scale up the microbial production of biomolecules.

For conventional, profit-seeking companies, moving into social impact carries huge contradictions.

Any company that decides to enter the mattress business is no doubt entranced by one undeniable fact: Everybody needs one.

Does the phrase “garbage in—garbage out” (GIGO) ring a bell? That’s the idea that if you use flawed, low-quality information to inform your decisions and actions, you’ll end up with a rubbish outcome.

The ideal of proactive quality has been the holy grail of chief quality officers in the life sciences industry for at least five years, but few, if any, have realized the vision.

One of the most significant developments of potential interest to small and medium-sized manufacturers in the area of industrial robots is the introduction about 10 years or so ago of a subset of industrial robots called collaborative robots or “cobots.”

During the last decade, we’ve witnessed the emergence of sustainability issues among the most important business concerns in a firm’s supply chain.

Research has shown that during economic uncertainty, companies that find a balance between reducing resources to survive and investing in key areas for growth will fare better through the recession and beyond.

With the increasing power of digital technology, the idea of a connected manufacturing system that can sense, analyze, and respond will soon be a reality.